According to J.P. Morgan, Metabolix MBLX coverage is initiated with a Neutral rating.
J.P. Morgan said that it initiates coverage of Metabolix with a Neutral rating and a December 2012 price target of $5.00. “We expect Metabolix to reach positive EPS in 2016. Our Neutral rating in part reflects the postponed profit stream of Metabolix.”
Metabolix closed on Friday at $4.33.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in